Literature DB >> 27577682

Mitochondrial genome architecture in non-alcoholic fatty liver disease.

Silvia Sookoian1, Diego Flichman2, Romina Scian1,3, Cristian Rohr4, Hernán Dopazo4, Tomas Fernández Gianotti3, Julio San Martino5, Gustavo O Castaño6, Carlos J Pirola3.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is associated with mitochondrial dysfunction, a decreased liver mitochondrial DNA (mtDNA) content, and impaired energy metabolism. To understand the clinical implications of mtDNA diversity in the biology of NAFLD, we applied deep-coverage whole sequencing of the liver mitochondrial genomes. We used a multistage study design, including a discovery phase, a phenotype-oriented study to assess the mutational burden in patients with steatohepatitis at different stages of liver fibrosis, and a replication study to validate findings in loci of interest. We also assessed the potential protein-level impact of the observed mutations. To determine whether the observed changes are tissue-specific, we compared the liver and the corresponding peripheral blood entire mitochondrial genomes. The nuclear genes POLG and POLG2 (mitochondrial DNA polymerase-γ) were also sequenced. We observed that the liver mtDNA of patients with NAFLD harbours complex genomes with a significantly higher mutational (1.28-fold) rate and degree of heteroplasmy than in controls. The analysis of liver mitochondrial genomes of patients with different degrees of fibrosis revealed that the disease severity is associated with an overall 1.4-fold increase in mutation rate, including mutations in genes of the oxidative phosphorylation (OXPHOS) chain. Significant differences in gene and protein expression patterns were observed in association with the cumulative number of OXPHOS polymorphic sites. We observed a high degree of homology (∼98%) between the blood and liver mitochondrial genomes. A missense POLG p.Gln1236His variant was associated with liver mtDNA copy number. In conclusion, we have demonstrated that OXPHOS genes contain the highest number of hotspot positions associated with a more severe phenotype. The variability of the mitochondrial genomes probably originates from a common germline source; hence, it may explain a fraction of the 'missing heritability' of NAFLD.
Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  NASH; fatty liver; gene expression; liver fibrosis; mitochondrial dysfunction; mitochondrial genome; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27577682     DOI: 10.1002/path.4803

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  26 in total

1.  Cell-free DNA methylation as liquid biopsy for the assessment of fibrosis in patients with nonalcoholic steatohepatitis: a gap between innovation and implementation.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 2.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 3.  Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease.

Authors:  Raghu Ramanathan; Ahmad Hassan Ali; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 4.  Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 5.  Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.

Authors:  Silvia Sookoian; Carlos J Pirola; Luca Valenti; Nicholas O Davidson
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

6.  Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease.

Authors:  Preeti Viswanathan; Yogeshwar Sharma; Luka Maisuradze; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Mol Pathol       Date:  2020-01-07       Impact factor: 3.362

7.  Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Cristian Rohr; Adrián Salatino; Hernán Dopazo; Tomas Fernandez Gianotti; Gustavo O Castaño; Carlos J Pirola
Journal:  Oncotarget       Date:  2017-04-04

8.  Foxo3a-dependent Bim transcription protects mice from a high fat diet via inhibition of activation of the NLRP3 inflammasome by facilitating autophagy flux in Kupffer cells.

Authors:  Yan Liu; Wenfeng Zhang; Xiaoling Wu; Jianping Gong
Journal:  Oncotarget       Date:  2017-05-23

Review 9.  Genetic predisposition in nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Clin Mol Hepatol       Date:  2017-03-09

Review 10.  Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity.

Authors:  Carlos J Pirola; Silvia Sookoian
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.